LifeTech Scientific's (HKG:1302) SureCham Aortic Arch Single-Branch Stent Graft System was admitted into the special examination and approval procedure for innovative medical devices by China's National Medical Products Administration.
The device was co-developed with Shu Chang's team at Fuwai Hospital, the Chinese Academy of Medical Sciences of the National Center for Cardiovascular Diseases, a Thursday bourse filing showed.
The product is indicated for the treatment of aortic dissection involving the aortic arch.